U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research | CDER
  5. Office of Infectious Diseases (OID)
  1. Center for Drug Evaluation and Research | CDER

Office of Infectious Diseases (OID)


The Office of Infectious Diseases (OID) consists of three review divisions: The Division of Anti-Infectives (DAI), the Division of Antivirals (DAV), and the Division of Pharm/Tox for Infectious Diseases (DPT-ID). The Immediate office oversees the development, review, and regulation of applications as well as issues related to toxicology for drug and biologic products reviewed in these divisions.

Immediate Office

Director: John Farley, M.D., MPH
Deputy Director: Adam Sherwat, M.D. (Acting)
Associate Director for Research: Thushi Amini, Ph.D.
Associate Director for Regulatory Science: Sunita Shukla, Ph.D., M.P.H.

Regulatory Operations
Director of Project Management Staff:
  Maureen Dillon-Parker (Acting)

Division of Anti-Infective (DAI)

Director: Sumathi Nambiar, M.D., M.P.H.
Deputy Director: Dmitri Iarikov, M.D., Ph.D.

Regulatory Operations
Chiefs of Project Management Staff:
Maureen Dillon-Parker and Carmen DeBellas

Division of Antiviral (DAV)

Director: Debra Birnkrant, M.D.
Deputy Director: Jeffery Murray, M.D., M.P.H

Regulatory Operations
Chief of Project Management Staff: 
Karen Winestock

OID Research Activities

Overview of research needs, requests for information (RFIs), public workshops/meetings, opportunities for collaboration, externally awarded research studies, and other important research.

OID Regulatory Science Activities

Contact Us

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation and Research
Office of Infectious Diseases
10903 New Hampshire Avenue
Silver Spring, MD 20993
Phone: (301) 796-1300
Fax: (301) 796-9887

Resources For You




Back to Top